Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FINALLY....EPGL Global Communications shall finally END on this last Trading Day of 2012
The REAL EPGL Medical Science.... a new DAWN BEGINS.
Get ready for 2013.
Did you remember to keep an eye on the 1st quarter of 2013.....I sure will be watching.
Until then, just flood your questions to investors@epglmed.com BEFORE January 3, 2013...starts at 6pm EST.
THAT will be the 5th Investors Q and A, and YOU have access to it, as a shareholder or even as an observer.
There will be new eyes getting ready to play.
The so called "profits" that others have been "claiming" right now from "EPGL Global Communications"is not even scratching the tip of the Iceberg or even near consideration of "chump change" especially what I just found out recently..... Its your choice.... see you there when the game changes with "EPGL Medical Sciences Inc."
I know the longs who are in for 2013 and I will see you there,
heh heh heh... EVERYONE finally has their chance....I only wonder about the new 20% rate...
Well to be honest I stopped around 10:20am and called it a day. Every time you see the yellow, it just broke new record... so there were more but Im not going to bother until Friday.
If the day ends in a negative, it still would not bother me one bit, but its looking good....
The more people that know about this stock the better, even if more skeptics starts spouting negativity we laugh in their face especially the time when I told others to get in when it was at .0039 and they scoffed back. Not my problem anymore.
Hey Wobblenuts and Jackie Scan I want to show you something....
Medical Breakthrough Wound Stasis Technology
ATRC and EPGL could possibly go hand in hand here...
Merry Christmas 2012
Merry Chirstmas 2012, friends.
Weak Hands can take their gains at any time, before EPGL (as of 12/23/12) with a status label of this" " turns into
EPGL Medical Sciences with a label of this ""
More than likely International which would give them this " "
(when pertaining to the current labeling on otcmarkets.com)
Only if the company is serious about everything they have said, and so far so good... although I need to point something out...go ahead and hate me for this...
They mentioned on 12/21/12 that:
EPGL Med @EPGLMed
At EPGL, the new year will bring OTC Current Information status for investors and a new name; EPGL Medical Sciences, Inc.
EPGL Med @EPGLMed
EPGL Biomems technology can more accurately deliver certain drugs to targeted tissues and regions of the body.
As you know EPGL Medical Science is an EPIC WIN... especially what you will see here 1st quarter of 2013.. don't forget to get your questions ready for January 3, 2013... send your questions NOW to investors@epglmed.com....THAT will be very beneficial and interesting... now I was sifting through old archives of people who doubted EPGL and yes it may be their own opinon, but it still gets a good laugh on what they said... for example... without naming names, I found a statement that someone said:
I say EPGL finishes 2012 at .004-.005 and 2013 will bring no real financials being filed, PWC selling their shares to recoup their investment, and minimal sales of a product that does not treat anything and those who do are already using something else.
Good luck.
Just to give you a heads up on EPGL recent tweet about Muscle Pain "Trigger Point"....
Tweet via through my PERSONAL BLACKBERRY:
@EPGLMed: New MPTT (Muscle Pain Triggerpoint Treatment) device in R&D, to utilize advanced BioMems technology. MPDD for detection, MPTT for treatment
Among MDs, many specialties are well versed in trigger point diagnosis and therapy. These include physiatrists (physicians specializing in physical medicine and rehabilitation), family medicine, and orthopedics. Osteopathic as well as Chiropractic schools, however, include trigger points in their training.[3] Other health professionals, such as occupational therapists, physiotherapists, acupuncturists, massage therapists and structural integrators are also aware of these ideas and many of them make use of trigger points in their clinical work as well.[4][5]
heh...(mid evil laugh)... its not just board members you have to look at...
There is a specific date I am eying on in mid 2013. Load up, sell, do whatever you want to do, the freedom is yours, I have my own agenda, as to each their own... but the current and upcoming rides will be enjoyable for the ones in the know.
The ending PPS on 12/28/12 which befalls on the final Friday of 2012 should be very interesting...
2013
and to think... number 8...
Those Tweets on 12/10/12.
EPGL Med @EPGLMed
David T. Markus PhD is now Vice President, BioMems Development for EPGL.
EPGL Med @EPGLMed
* EPGL owns unique IP and know-how in BioMems with several applications currently in development.
EPGL Med @EPGLMed
Biomedical, MicroElectroMechanical Systems (BioMems) will become a core focus for EPGL moving forward.
EPGL Med @EPGLMed
Select EPGL team members concluded meetings in Irvine, CA last week regarding BioMems technology.
If you remembered last week on 12/5/12 they mentioned:
OTC update progressing. EPGL will be OTC "Current Information" shortly before year end.
My Friends, Im flying to Japan for a day to check up on something a friend of mine wants to tell me about EPGL in person.... Ok so I find things out from her sometimes, so what... if it helps in the long run, EPGL Medical Science sounds fine with me. Pros and Cons.. but mostly Pros so far and Im ok with that.
2013 "Get Ready What Might Happen" she just told me.
I need to know what the hell she is talking about!....
Current Information Shortly before year end.....
OTC update progressing. EPGL will be OTC "Current Information" shortly before year end.
Serious dumpers would have unloaded over 10 million shares in one day, as they claim to hold so many they say, but they have not. The weak dumps today are going to be providing more opportunity and little do they know and more likely they could care less... but they just bought some time for others. Use this time as an advantage.
With Eyes Red this scenario is nothing new to me.
2012 December/b]
I had a feeling EPGL will be slowly creeping its way through DARPA News.... see below
http://www.redorbit.com/topics/darpa/
With EPGL Medical Sciences BioMEMS Research and Development Plans and initial phases, Walter Reed Medical... former employee of Raytheon Defense Tech....if you have no idea what DARPA is, you can see a peek of it at number 8 of this interesting video.
Walter Reed National Military Medical Center
"Where the Nation Heals its Heroes..."
Heh Heh... (Mid Evil Laugh)...it is still 2012
Im glad certain ones can see something straight ahead, instead of the petty squabbles that I just recently read... I see a select few have an idea what is coming soon on the absurd/lucrative positive end of OTCQX...As you know... when this current "new" company of verified Medics taking over the "old" EPGL says something... they actually do it...EPGL Medical Science...HOWEVER, it is still NOVEMBER 2012... how easily people forget and drift off to some other panicked speculation of an investor concern. This stays strong, you will be just fine. I do not need to show you charts, you can see that for yourself.
If you must dump, then I will gladly say goodbye to you and let the new investors in the loop and let them realize their gain.
EPGL 4th Q and A Investor Relations 11.28.12 Archived
EPGL Med @EPGLMed
Good Evening. Welcome to tonight's Q&A which will go until 6:30PM EST or until no more questions, whichever is first.
EPGL Med @EPGLMed
Yes, to clarify: 499 mm outstanding 5B authorized. Approx 4.5B will be restricted Approximately 499mm outstanding float foreseeable future.
EPGL Med @EPGLMed
BioMems is Biological Microelectromechanical Systems.
EPGL Med @EPGLMed
Yes, this is the leading edge of medicine treatment and diagnosis, delivery of drugs and implantable devices.
EPGL Med @EPGLMed
We will be continuing to update OTC to Current information. Then we will begin process to become OTCQX. Our goal is to put EPGL on Nasdaq or NYSE. This will take some time to accomplish, but this is the plan.
EPGL Med @EPGLMed
The balance sheet reflects all assets EPGL has as listed.
EPGL Med @EPGLMed
With the technologies we have in development and the team of people we have , yes we believe the valuations are if anything, conservative.
EPGL Med @EPGLMed
That does not mean, however that market events and developments with competition, cannot have an impact on values. But we are confident that the technologies we have in house, have significant value going forward in the medical device industry.
EPGL Med @EPGLMed
Without being specific, the core technology we are developing in BioMems has several device applications that will result. Many many, apps.
EPGL Med @EPGLMed
Yes, we are accepting pre-orders on MPDD and we continue to have great demand and interest building for the rollout in 2013.
EPGL Med @EPGLMed
Accuracy and precise delivery of diagnosis and treatment is the mission of EPGL devices. We are on that track with our developing pipeline.
EPGL Med @EPGLMed
Matt, tonight's session will not give specific dates and times on any releases yet. We do not want to do that until closer to the time.
EPGL Med @EPGLMed
Matt, EDGAR filings will be coming in the future as we continue to climb the OTC Tiers. Maybe sooner than later. We shall see.
EPGL Med @EPGLMed
We have sent a test marketing piece for the MPDD to approximately 5,000 Physicians. We have had a tremendous response resulting in several hundred placements in line for pre-orders and requests for more info.
EPGL Med @EPGLMed
We will continue priming physicians worldwide with pre-marketing materials which result in direct response.
EPGL Med @EPGLMed
However, when the MPDD is rolled out, we will be utilizing the services of a major distribution channel to be announced.
EPGL Med @EPGLMed
We have not accepted any offers as yet from organizations wishing to purchase major blocks of equity. That is still being evaluated.
EPGL Med @EPGLMed
We enjoy a close connection with the US Military and anticipate a good relationship going forward, utilizing the technologies we have.
EPGL Med @EPGLMed
Because of fluid developments with potential financial investors and partners, we are keeping certain key board positions and
Officer positions open until such time as we can solidify discussions going on presently. As soon as we know, you will know immediately.
EPGL Med @EPGLMed
Thanks to all. Have a great evening. We will do this regularly.
..............
My current questions have been answered, I am satisfied with this undervalued gift. The following you just read were from EPGL responses to questions sent to them and the time expired past 6:30pm EST. (3:30pm Pacific Standard Time) From 11.28.12
YES and THANK YOU.
Send Your Questions To EPGL Before Deadline
Send Your Questions To: investors@epglmed.com
Quick recap:
As a shareholder, it would be wise to ask them any questions that may or may not concern your holdings of EPGL. The Q and A begins Tomorrow...at 3pm EST... Wednesday.
According to their tweet, the PR will be released LATE AFTERNOON... more than likely once the Q and A is over..
EPGL will release its next PR for investors Wednesday November 28, late afternoon EST
SEE YOU THERE AT THE NEXT EPGL Q and A
EPGL holds its fourth investor Q&A next week November 28 at 6:00 PM EST. Submit questions live or in advance at investors@epglmed.com
LOL thanks Cable, You just verified MarketWatch, PR Newswire has "Follow Us on Twitter" button on their sites.... even Bloomberg...I see...
EPGL using Twitter should not really affect modern traders comfort zone, unless they are the traditional old fashioned 1950's style rotary telephone traders waiting for the typewriter Morse code news.
Its pretty much Holiday Week, well, EPGL will have more news coming after the Thanksgiving Holiday...Thanks again Cable, I actually needed that dark humor refresher to start the day.
...
http://www.businessweek.com/stories/2008-09-06/how-companies-use-twitter-to-bolster-their-brandsbusinessweek-business-news-stock-market-and-financial-advice
A growing number of companies are keeping track of what's said about their brands on Twitter. Comcast (CMCSA), Dell (DELL), General Motors (GM), H&R Block (HRB), Kodak (EK), and Whole Foods Market (WFMI) are among a handful of companies haunting Twitter to do everything from ....
Why EPGL uses ATRC as an example, chart
The following chart is ATRC, which is also a medical device company. Since EPGL mentions them as an example of where our EPGL shares are headed, you will see that on April 27, 2009, the ATRC PPS was $1.11 and then.....
2 years and 2.5 months later on July 4, 2011, the PPS around $14.
A massive dump to the bottom and in 2 years back to the top...
The Company (ATRC) has two primary product lines for the ablation of cardiac tissue. Its primary product line, which accounts for a majority of its revenues is the AtriCure Synergy Ablation System, a bipolar ablation clamp system and related radiofrequency ablation devices.
If you have to be reminded again, EPGL initiated R & D (Research and Development) on 4 new medical devices before end of 2012. People easily forget that our EPGL has strong ties with the US Military and how military doctors are impressed with their capabilities.... and one that mentioned that cursed name "Raytheon" should make the rest of us true investors laugh all the way to the bank in due time.
How much I hate hearing those "Kerr-sed" big names...
EPGL is THE STOCK to make money from.
I also strongly agree on what Black8 says and am pleased with the recent gradual small climb.
The point is, it does not take much money to invest at this current stage to reap returns, in special case scenarios of gains over 500% let alone over 1000%, this would be a remarkable opportunity and open to all new future investors out there. Once Tuesday passes, if they accelerate to achieving OTCQX status thereafter, that alone, will be .10 pps minimum.
Its a good thing that people need to be reminded of this, especially in how easily they forget.
Watch out for large sell offs before QTCQX.
Ive seen this before and if you want to keep your profits I suggest you remember EPGL goal of reaching OTCQX first.... I sense a "Newsletter" group trying to take advantage of a 2 day delay after comparing this chart to 3 other sources I looked up on.... Although I will be watching Friday AND Monday. The irony is, those people who want "quick cash" won't even realize its not even 2013 yet.
Scroll Down.
EPGL 11/16/12 REPORTING DELAYED
Tweet
EPGL Med @EPGLMed
Delay related to Sandy and affected operations of our financial team in NYC. EPGL OTC Update will happen Tuesday, November 20, 2012.
EPGL Med @EPGLMed
OTC Update could happen sooner if things line up according to accountants in NYC. Stay tuned... But Tuesday at latest.
All this means is more accumulation opportunity, thanks.
I'm looking at a slow gradual increase....
If you remembered this article from August PRWEB
First advance orders for new MPDD devices are now being received from physicians and the Company is anticipating very strong demand in 2013 after worldwide distribution release. The MPDD devices will initially be marketed under the therapeutic label and later will be marketed under the diagnostic label with an additional FDA 510k. MPDD devices will be priced between $12,000.00 and $20,000.00 depending on the package level of training and education purchased by physicians and health organizations. The Company will market to pain physicians, primary physicians, Internists, sports medicine physicians and physical therapists to name just a few in the significant market for the MPDD device. The MPDD device is only the first of several products which the Company will market in the months and years ahead as the Company is extremely interested in the promising field of bioelectronics and non-opioid treatments of pain.
Shareholders are the most important asset to EPGL Med. The Company is committed to growing significant market capitalization and shareholder returns. To this end, the Company is now taking requisite steps to resume full reporting status and move up to OTCBB in the near future. New financial statements and filings will begin by end of year 2012.
The MPDD devices will initially be marketed under the therapeutic label and later will be marketed under the diagnostic label with an additional FDA 510k.
Lets see if EPGL will end up as what "Ruby Tuesday" did, (example of a penny company) today's date is November 8, 2012.
As you may have known, that company as an example, was a penny share that eventually reached a high past $30. This of course if good fortunes comes through 2013 and beyond.... and after I personally spoke to a few doctors when I went to Japan just recently... heh....
Buy To Cover.. works for EPGL as well as any other.
__________________________________________________________________
Definition of 'Buy To Cover'
A buy order made on a stock or other listed security that closes out an existing short position. A short sale involves selling shares of a company that one does not own, as the shares are borrowed and need to be re-paid at some point. This order, by buying an equal number of shares as were borrowed, "covers" the sale and the shares can be returned to the original lender of them. The lender will typically be the investor's own broker/dealer but their broker may have had to borrow the shares from a third party.
Here is simpler explanation.
For the investor who has bet on a stock price going down, the hope is to be able to buy the shares back at a lower price than the original short was executed at. There is no timetable for the short investor to follow, so they can wait as long as they wish to repurchase the shares. However, if the stock begins to rise above the price the shares were shorted at, the investors' broker may require them to execute a buy to cover order as part of a margin call. To prevent this from happening, investors should always keep enough buying power in their account to make a "buy to cover" trade based the current market price of the stock.
__________________________________________________________________
However, if you do not have the time to "play" and only are looking for the direct profits, then you better hold onto your positions tight and LOCK yourself in for a long strategic play. In any case, The next 7 Market days from today might as well be considered "Free Lunch" for the taking before their "Progress Report" on the 16th of November.... It can turn the handle very slowly, or kick in the door...